Sponsor or institution

Clinical trials and research at Sarcoma Alliance for Research through Collaboration

• 2Clinical trials
• 2Countries

All recruiting trials (2)

• Nab‑sirolimus for progressing or symptomatic epithelioid hemangioendothelioma

  We will try nab‑sirolimus given by IV on Days 1 and 8 of a 21‑day cycle in adults with progressing or symptomatic epithelioid hemangioendothelioma who need systemic treatment.

  Recruiting at 4 sites Phase 2 Sarcoma Alliance for Research through Collaboration · Stanford, California and 5 other locations · NCT07104331

• Weekly tebentafusp for adults with HLA-A*02:01-positive unresectable or metastatic clear cell sarcoma

  This trial tests weekly tebentafusp in adults with unresectable or metastatic HLA-A*02:01-positive clear cell sarcoma to see if it controls tumor growth.

  Recruiting at 4 sites Phase 2 Sarcoma Alliance for Research through Collaboration · Los Angeles, California and 3 other locations · NCT06942442

Quick answers

How many clinical trials run by Sarcoma Alliance for Research through Collaboration are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (2 trials), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →